Insulet | PODD - Current Liabilities




Insulet reported $528.4M in Current Liabilities for its fiscal quarter ending in December of 2024.

Current Liabilities Change Date
Abbott USD 14.16B 745M Dec/2024
Align Technology USD 2.04B 25.58M Dec/2024
AtriCure USD 73.42M 1.01M Dec/2024
Avanos Medical USD 212.9M 4.7M Sep/2024
Baxter International USD 6.51B 311M Dec/2024
Becton, Dickinson and Co. USD 7.66B 1.28B Dec/2024
Boston Scientific USD 6.4B 489M Dec/2024
Cardinal Health USD 35.22B 545M Dec/2024
Cooper Companies USD 1.02B 53.3M Oct/2024
Dexcom USD 2.93B 1.2B Dec/2024
Edwards Lifesciences USD 1.94B 727.1M Sep/2024
Eli Lilly USD 24.67B 2.45B Sep/2024
Globus Medical USD 855.91M 37.85M Dec/2024
ICU Medical USD 549.56M 37.65M Sep/2024
Insulet USD 528.4M 22.2M Dec/2024
Integra LifeSciences USD 912.56M 584.24M Sep/2024
J&J USD 51.76B 2.17B Sep/2024
Masimo USD 637.6M 91.4M Sep/2024
Medtronic USD 11.84B 355M Jan/2025
Merit Medical Systems USD 201.08M 14.86M Sep/2024
Roche Holding CHF 27.02B 424M Dec/2024
Solventum Corp 2.9B 333M Sep/2024
Stryker USD 7.62B 53M Dec/2024
Tandem Diabetes Care USD 259.28M 18.67M Sep/2024
Teleflex USD 618.75M 62M Sep/2024
West Pharmaceutical Services USD 550.4M 33.9M Dec/2024
Zimmer Biomet Holdings USD 2.45B 1.12B Dec/2024